Melanoma is a type of skin cancer. It starts in the cells that produce melanin, the pigment that gives skin its color. Melanoma can develop anywhere on the body, but it most often appears on the skin. It's important to see a doctor if you notice a new or changing mole or spot.
Every report comes from a Lived member, sent anonymously.
Have you tried Keytruda (Pembrolizumab) for Melanoma?
Melanoma is a cancer that starts in melanocytes, the cells that give skin its pigment. It is far less common than other skin cancers but more likely to spread to lymph nodes and other organs, which makes it the most serious form and makes early detection matter. The main warning sign is a new spot, or a mole that changes in size, shape or color. A spot that looks different from a person's other moles also deserves attention. The ABCDE guide (asymmetry, an irregular border, uneven color, a diameter over about 6 millimeters and evolving over time) describes what to watch for. Anyone can get melanoma, including people with dark skin, and it can start in less obvious places: as a dark streak under a nail, on the palms or soles, or in the mouth, nose or genitals. A rarer form starts in the eye and is treated differently.
Ultraviolet (UV) light from the sun and tanning beds is a major risk factor, because it damages the genetic material in skin cells. Risk is also higher with fair skin that burns easily, blistering sunburns when young, many moles or unusual-looking ones, a personal or family history of melanoma, and a weakened immune system. These factors raise the odds without deciding the outcome, and melanomas on the palms, soles and nails are not tied to sun exposure in the same way.
A skin exam finds suspicious spots, but only a biopsy can confirm melanoma: all or part of the spot is removed and examined under a microscope. Staging then describes how far it has gone, based on how thick the tumor is, whether the skin over it has broken open (ulceration), and whether it has reached lymph nodes or distant organs. For adults with no symptoms and no personal or family history of skin cancer, the US Preventive Services Task Force found too little evidence to say whether routine clinician skin checks help. That does not apply to anyone with a changing spot or a history of skin cancer.
Surgery to remove the melanoma with a margin of normal skin is the main treatment at every stage, and for thin, early melanoma it is often enough. Many people also have a sentinel lymph node biopsy, which checks the first lymph node the cancer would likely reach. When melanoma is likely to come back or has spread, medicines are added. Immunotherapy with checkpoint inhibitors, such as pembrolizumab (Keytruda) or nivolumab (Opdivo), releases a brake on the immune system so it can attack the cancer. About half of melanomas carry a change in a growth-signaling gene called BRAF, and targeted drugs that block that signal are another option for them. Radiation and chemotherapy mainly relieve symptoms.
Outlook depends mostly on stage. In US data, about three quarters of melanomas are found before they spread, and their five-year relative survival (compared with similar people without melanoma) is close to 100 percent. It is about 76 percent with spread to nearby lymph nodes and about 34 percent with distant spread. These are group figures, not a personal forecast. Melanoma can come back, and anyone who has had one is more likely to get another, so follow-up visits, regular skin checks and sun protection continue for years.
See a clinician about a new or changing spot, one that looks unlike the others, a sore that doesn't heal, a mole that bleeds or itches, or a new dark streak under a nail. During or after immunotherapy, contact the cancer care team right away about any new symptom, such as diarrhea, a cough, a rash or a fever. Checkpoint inhibitors can turn the immune system against healthy organs, sometimes seriously and even after treatment ends.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Melanoma is like, what's helped you, or ask the community a question.